Beneficial effects of the 2‐day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Hepatology

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(98)80151-7PMID 9824265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

  1998cited by this paper
• Hepatorenal Syndrome

  1997cited by this paper
• Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

  1996cited by this paper
• Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

  1996cited by this paper
• The role of atrial natriuretic peptide (ANP) in chronic liver disease.

  1993cited by this paper
• Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

  1993cited by this paper
• Atrial natriuretic peptide: synthesis, release, and metabolism.

  1992cited by this paper
• Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate.

  1992cited by this paper
• Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis: Effects on renal hemodynamics and atrial natriuretic factor

  1991cited by this paper
• Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor.

  1991cited by this paper
• Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis

  1988cited by this paper
• Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites.

  1986cited by this paper
• [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].

  1985cited by this paper
• Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

  1982cited by this paper

• Impact of long-term continuous terlipressin infusion on the renin-angiotensin-aldosterone system in patients with decompensated cirrhosis

  2025cites this paper
• Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury.

  2023cites this paper
• Practice guidance for the use of terlipressin for liver cirrhosis–related complications

  2022cites this paper
• Abnormal brain oxygen homeostasis in an animal model of liver disease

  2022cites this paper
• Randomized Trials of Interventions for Hospitalized Patients with Cirrhosis.

  2021cites this paper
• Approaches for patients with very high MELD scores

  2019cites this paper
• Vasoconstrictors in hepatorenal syndrome - A critical review.

  2019cites this paper
• Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.

  2018cites this paper
• Insuffisance rénale aiguë et syndrome hépatorénal chez le patient cirrhotique : actualités diagnostiques et thérapeutiques

  2018cites this paper
• Kidney Injury and Electrolyte Abnormalities in Liver Failure

  2018cites this paper
• HEPATORENAL SYNDROME: A REVIEW

  2018cites this paper
• Hepatorenal syndrome: the clinical impact of vasoactive therapy

  2018cites this paper
• Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis.

  2017cites this paper
• New Developments in Hepatorenal Syndrome

  2017cites this paper
• Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis

  2017cites this paper
• Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.

  2017cites this paper
• Vasoactive Drugs, Renal Function, and Acute Kidney Injury

  2017cites this paper
• Challenges in Renal Failure Treatment Before Liver Transplant.

  2017cites this paper
• Systematic review with meta‐analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1

  2017cites this paper
• Determine the frequency of hepatorenal syndrome in patients with cirrhosis associated with Hepatitis C

  2017cites this paper
• Perioperative terlipressin infusion in living donor liver transplantation: effects on sodium and water balance

  2017cites this paper
• Terlipressin versus other vasoactive drugs for hepatorenal syndrome.

  2017cites this paper
• Despair of Treatment: A Qualitative Study of Cirrhotic Patients' Perception of Treatment

  2017cites this paper
• TERLIPRESSIN THERAPY RESPONSE ASSESSED BY COLOUR DOPPLER IMAGING IN PATIENTS OF HEPATORENAL SYNDROME

  2017cites this paper
• Outcomes of liver transplantation in patients with hepatorenal syndrome.

  2016cites this paper
• Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation

  2016cites this paper
• Hepatorenal syndrome: Current concepts related to diagnosis and management.

  2016cites this paper
•  Hepatorenal syndrome: Current concepts related to diagnosis and management.

  2016cites this paper
• Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.

  2016cites this paper
• Hepatorenal Disorders.

  2015cites this paper
• Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis

  2015cites this paper
• Chapter 74 – Renal Failure in Adults

  2015cites this paper
• Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome.

  2015cites this paper
• UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE - UFCSPA CURSO DE PÓS-GRADUAÇÃO EM HEPATOLOGIA

  2014cites this paper
• Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

  2014cites this paper
• Current Therapies for Hepatorenal Syndrome

  2014cites this paper
• Hepato-Renal Syndrome: A Complication of Advanced Chronic Liver Disease with Portal Hypertension

  2013cites this paper
• Cirrhotic ascites review: Pathophysiology, diagnosis and management.

  2013cites this paper
• Hepatorenal Syndrome and Novel Advances in its Management

  2013cites this paper
• Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis

  2013cites this paper
• Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation.

  2013cites this paper
• Perioperative Assessment of Terlipressin Infusion during Living Donor Liver Transplantation

  2012cites this paper
• Clinical profile of hepatorenal syndrome: a prospective study.

  2012cites this paper
• Terlipressin for hepatorenal syndrome.

  2012cites this paper
• Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature.

  2012cites this paper
• Medical management of hepatorenal syndrome.

  2012cites this paper
• Acute Liver Failure in Intensive Care

  2012cites this paper
• Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2012cites this paper
• Insufficienza epatica acuta in terapia intensiva

  2011cites this paper
• Hepatorenal syndrome

  2011cites this paper
• Terlipressin in Hepatorenal Syndrome

  2011cites this paper
• Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis

  2011influential citation
• Critical care management of patients with end-stage liver disease

  2011cites this paper
• S3-Leitlinie „Aszites, spontan bakterielle Peritonitis, hepatorenales Syndrom”

  2011cites this paper
• Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.

  2011cites this paper
• Renal protection during liver transplantation: an ounce of prevention is worth a pound of cure.

  2011influential citation
• Vasoconstrictor Therapy for Hepatorenal Syndrome

  2011cites this paper
• Management of hepatorenal syndrome in patients with cirrhosis

  2011cites this paper
• Acute and chronic liver insufficiency

  2010cites this paper
• Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials

  2010cites this paper
• The use of terlipressin in hepatorenal syndrome

  2010cites this paper
• Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.

  2010cites this paper
• Acute kidney injury: Specific interventions and drugs

  2010cites this paper
• Ascites, Hepatorenal Syndrome, and Spontaneous Bacterial Peritonitis

  2010cites this paper
• Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

  2010cites this paper
• Management of Acute Esophageal Variceal Hemorrhage

  2010cites this paper
• Physiology of kidney renin.

  2010cites this paper
• Management of Ascites

  2009cites this paper
• Two Observations Raising Questions about Risk Factors of Cutaneous Necrosis Induced by Terlipressin (Glypressin®)

  2009cites this paper
• Terlipressin for Hepatorenal Syndrome: A Meta-Analysis of Randomized Trials

  2009influential citation
• Avances en el tratamiento de la cirrosis hepática. Aplicaciones a la práctica clínica

  2009cites this paper
• 6 Portale hypertensie

  2009cites this paper
• [Hepatorenal syndrome].

  2009cites this paper
• Combination Treatment With Octreotide, Midodrine, and Albumin Improves Survival in Patients With Type 1 and Type 2 Hepatorenal Syndrome

  2009cites this paper
• Renal haemodynamics and function following partial portal decompression.

  2009cites this paper
• Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.

  2009cites this paper
• Expertise Médicale Continue en néphrologieSyndrome hépatorénalHepatorenal syndrome

  2009cites this paper
• Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.

  2009cites this paper
• Comment traiter une ascite ? - Comment traiter un syndrome hépato-rénal

  2008cites this paper
• Pharmacologic Approaches for Volume Excess in Acute Kidney Injury (AKI)

  2008cites this paper
• Ascitis y síndrome hepatorrenal en la cirrosis hepática

  2008cites this paper
• Hepatorenal syndrome in cirrhosis

  2008cites this paper
• Acute Kidney Injury: New Concepts

  2008cites this paper
• Vasoconstrictor therapy for the hepatorenal syndrome.

  2008cites this paper
• Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

  2008cites this paper
• An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

  2008cites this paper
• Vasopressin in liver disease--should we turn on or off?

  2008cites this paper
• Arginine vasopressin vs. terlipressin in the treatment of shock states.

  2008cites this paper
• A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

  2008cites this paper
• Pathogenetic background for treatment of ascites and hepatorenal syndrome

  2008cites this paper
• Acute kidney injury in cirrhosis

  2008cites this paper
• Session 6 ‒ Treatment of the Acute Bleeding Episode

  2008cites this paper
• Chapter 5 – Management of Hepatorenal Syndrome

  2008cites this paper
• Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

  2008cites this paper
• Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage.

  2008cites this paper
• The hepatorenal syndrome.

  2008cites this paper
• Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome

  2007cites this paper
• Hepatorenal syndrome.

  2007cites this paper
• Syndrome hépato-rénal

  2007cites this paper
• Hepatorenal syndrome: an update

  2007cites this paper